Bioventus Inc. (BVS) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | $53.98M | +455.2% |
| 2024 | -$15.20M | +81.4% |
| 2023 | -$81.72M | +51.1% |
| 2022 | -$167.23M | -1486.6% |
| 2021 | $12.06M | -43.2% |
| 2020 | $21.24M | -31.9% |
| 2019 | $31.19M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | $53.98M | +455.2% |
| 2024 | -$15.20M | +81.4% |
| 2023 | -$81.72M | +51.1% |
| 2022 | -$167.23M | -1486.6% |
| 2021 | $12.06M | -43.2% |
| 2020 | $21.24M | -31.9% |
| 2019 | $31.19M | — |